tiprankstipranks
Krystal Biotech (DE:4KB)
XETRA:4KB
Germany Market
4KB
Krystal Biotech
RESEARCH TOOLSreports

Krystal Biotech (4KB) Ratios

1 Followers

Krystal Biotech Ratios

DE:4KB's free cash flow for Q2 2026 was $0.95. For the 2026 fiscal year, DE:4KB's free cash flow was decreased by $ and operating cash flow was $0.55. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 8.32 9.95 7.28 17.76 13.30
Quick Ratio
 7.96 9.56 7.02 17.55 13.30
Cash Ratio
 3.36 4.82 3.38 10.83 5.61
Solvency Ratio
 1.74 1.85 0.88 0.42 -3.77
Operating Cash Flow Ratio
 2.14 1.95 1.21 -2.68 -3.49
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 918.13M$ 910.37M$ 632.59M$ 548.20M$ 347.56M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.02
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 0.01 0.02
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.10 1.09 1.12 1.05 1.07
Debt Service Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.30 0.32 0.25 0.30 0.35
Net Debt to EBITDA
 -1.92 -2.48 -3.07 3.84 1.31
Profitability Margins
Gross Profit Margin
93.34%92.61%93.09%93.90%0.00%
EBIT Margin
48.43%48.69%35.52%-191.77%0.00%
EBITDA Margin
49.59%50.37%37.83%-180.11%0.00%
Operating Profit Margin
44.93%41.45%22.61%-216.43%0.00%
Pretax Profit Margin
51.45%48.69%32.82%25.44%0.00%
Net Profit Margin
54.82%52.64%30.69%21.56%0.00%
Continuous Operations Profit Margin
54.82%52.64%30.69%21.56%0.00%
Net Income Per EBT
106.55%108.11%93.50%84.76%100.00%
EBT Per EBIT
114.50%117.47%145.15%-11.75%96.40%
Return on Assets (ROA)
16.09%15.36%8.44%1.34%-25.06%
Return on Equity (ROE)
19.34%16.80%9.42%1.40%-26.80%
Return on Capital Employed (ROCE)
14.41%13.10%6.89%-13.97%-27.42%
Return on Invested Capital (ROIC)
14.39%13.09%6.43%-11.82%-27.34%
Return on Tangible Assets
16.09%15.36%8.44%1.34%-25.06%
Earnings Yield
2.43%2.87%1.99%0.32%-6.93%
Efficiency Ratios
Receivables Turnover
 3.18 3.05 2.77 1.21 0.00
Payables Turnover
 4.48 8.89 4.02 1.67 0.00
Inventory Turnover
 0.64 0.71 0.76 0.44 0.00
Fixed Asset Turnover
 2.74 2.46 1.80 0.30 0.00
Asset Turnover
 0.29 0.29 0.28 0.06 0.00
Working Capital Turnover Ratio
 0.48 0.50 0.49 0.11 0.00
Cash Conversion Cycle
 600.22 591.89 523.20 908.56 0.00
Days of Sales Outstanding
 114.90 119.52 131.60 302.66 0.00
Days of Inventory Outstanding
 566.73 513.45 482.30 824.02 0.00
Days of Payables Outstanding
 81.41 41.08 90.70 218.13 0.00
Operating Cycle
 681.63 632.97 613.90 1.13K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 9.22 6.94 4.32 -3.27 -3.95
Free Cash Flow Per Share
 8.73 6.53 4.17 -3.70 -6.02
CapEx Per Share
 0.49 0.41 0.15 0.43 2.08
Free Cash Flow to Operating Cash Flow
 0.95 0.94 0.97 1.13 1.53
Dividend Paid and CapEx Coverage Ratio
 18.71 16.81 29.12 -7.53 -1.90
Capital Expenditure Coverage Ratio
 18.71 16.81 29.12 -7.53 -1.90
Operating Cash Flow Coverage Ratio
 30.76 21.51 17.00 -10.97 -11.26
Operating Cash Flow to Sales Ratio
 0.62 0.52 0.42 -1.75 0.00
Free Cash Flow Yield
2.60%2.65%2.66%-2.99%-7.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 40.71 34.82 50.21 308.15 -14.43
Price-to-Sales (P/S) Ratio
 22.53 18.34 15.42 66.45 0.00
Price-to-Book (P/B) Ratio
 7.31 5.85 4.73 4.33 3.87
Price-to-Free Cash Flow (P/FCF) Ratio
 38.50 37.77 37.58 -33.49 -13.15
Price-to-Operating Cash Flow Ratio
 36.51 35.53 36.29 -37.93 -20.08
Price-to-Earnings Growth (PEG) Ratio
 0.65 0.27 0.07 -2.87 -0.19
Price-to-Fair Value
 7.31 5.85 4.73 4.33 3.87
Enterprise Value Multiple
 43.52 33.92 37.68 -33.06 -15.98
Enterprise Value
 9.51B 6.65B 4.14B 3.02B 1.87B
EV to EBITDA
 43.52 33.92 37.68 -33.06 -15.98
EV to Sales
 21.58 17.09 14.26 59.54 0.00
EV to Free Cash Flow
 36.88 35.20 34.75 -30.00 -12.16
EV to Operating Cash Flow
 34.91 33.10 33.56 -33.99 -18.56
Tangible Book Value Per Share
 46.03 42.14 33.10 28.68 20.49
Shareholders’ Equity Per Share
 46.03 42.14 33.10 28.68 20.49
Tax and Other Ratios
Effective Tax Rate
 -0.07 -0.08 0.06 0.15 0.00
Revenue Per Share
 14.92 13.44 10.16 1.87 0.00
Net Income Per Share
 8.18 7.08 3.12 0.40 -5.49
Tax Burden
 1.07 1.08 0.94 0.85 1.00
Interest Burden
 1.06 1.00 0.92 -0.13 1.16
Research & Development to Revenue
 0.13 0.15 0.18 0.92 0.00
SG&A to Revenue
 0.36 0.38 0.39 0.00 0.00
Stock-Based Compensation to Revenue
 0.09 0.14 0.17 0.79 0.00
Income Quality
 1.13 0.98 1.38 -8.12 0.72
Currency in USD